Business Context and Reporting Period
This Form 8-K is a current report filed by Tharimmune, Inc. (not Canton Strategic Holdings, Inc.) on May 9, 2025. The registrant is a Delaware corporation with its principal executive offices in Bridgewater, NJ, and its common stock trades on The Nasdaq Stock Market under the symbol THAR. The company is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is a leadership transition within the Board of Directors:
- Appointment: Vincent LoPriore, a current director, was appointed as Executive Chairman of the Board, effective immediately on May 9, 2025.
- Departure: Randy Milby, who previously served as Chairman of the Board, was replaced by Mr. LoPriore in that specific capacity.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations, risks, contingencies, or unusual items. The document is limited to the disclosure of the officer appointment under Item 5.02.
Investor Verification Checklist
- Verify the exact scope of Randy Milby's remaining role, as he signed the report as Chief Executive Officer despite stepping down as Chairman.
- Confirm if Vincent LoPriore's appointment as Executive Chairman involves any new compensatory arrangements not detailed in this filing.
- Review subsequent filings for any financial updates, as this 8-K contains no financial metrics.